Serine/threonine protein kinase
From Proteopedia
(Difference between revisions)
| Line 471: | Line 471: | ||
**[[4otn]] – mChk Gcn2 C terminal domain <br /> | **[[4otn]] – mChk Gcn2 C terminal domain <br /> | ||
| - | *Pim-2 | + | *'''Pim-2''' |
**[[4x7q]] – hPim2 + inhibitor <br /> | **[[4x7q]] – hPim2 + inhibitor <br /> | ||
| + | |||
| + | *'''Hipa''' and '''Hipa''' | ||
| + | |||
| + | **[[3tpd]], [[3tpe]] – EcChk Hipa – ''Escherichia coli''<br /> | ||
| + | **[[3tpb]], [[3dnt]], [[3dnu]] – EcChk Hipa (mutant) <br /> | ||
| + | **[[4pu7]], [[4pu8]] – SoChk Hipb - ''Shewanella oneidensis''<br /> | ||
| + | **[[3tpt]] – EcChk Hipa (mutant) + ADP<br /> | ||
| + | **[[3fbr]] – EcChk Hipa (mutant) + AMPPNP + peptide<br /> | ||
| + | **[[3tpv]] – EcChk Hipa + ADP<br /> | ||
| + | **[[2wiu]] – EcChk Hipa + Hipb <br /> | ||
| + | **[[4yg7]], [[5k98]], [[3hzi]], [[3dnv]] – EcChk Hipa + Hipb + DNA<br /> | ||
| + | **[[4yg1]], [[4z58]], [[4z59]], [[4z5c]], [[4z5d]] – EcChk Hipb + DNA<br /> | ||
| + | **[[4z5h]] – EcChk Hipb (mutant) + DNA<br /> | ||
| + | **[[4pu3]], [[4pu4]] – SoChk Hipa + Hipb + DNA - ''Shewanella oneidensis''<br /> | ||
| + | **[[4pu5]] – SoChk Hipa + AMPPNP<br /> | ||
*'''Other Chk''' | *'''Other Chk''' | ||
| Line 486: | Line 501: | ||
**[[1how]], [[1zxe]], [[1zy4]] – yChk (mutant)<br /> | **[[1how]], [[1zxe]], [[1zy4]] – yChk (mutant)<br /> | ||
**[[1ow5]], [[1x9x]] – yChk Ste11 SAM domain – NMR<br /> | **[[1ow5]], [[1x9x]] – yChk Ste11 SAM domain – NMR<br /> | ||
| - | **[[2kio]], [[2kit]] – yChk Tor1 FATC domain – NMR<br /> | + | **[[2kio]], [[2kit]], [[1w1n]] – yChk Tor1 FATC domain – NMR<br /> |
**[[3gre]] – yChk Vps15 WD repeat domain<br /> | **[[3gre]] – yChk Vps15 WD repeat domain<br /> | ||
**[[3osm]], [[3ost]] - yChk Kcc4 kinase domain <br /> | **[[3osm]], [[3ost]] - yChk Kcc4 kinase domain <br /> | ||
**[[1uf0]] – hChk Dcamkl1 DCX domain – NMR<br /> | **[[1uf0]] – hChk Dcamkl1 DCX domain – NMR<br /> | ||
| - | **[[1xte]], [[1xtn | + | **[[1xte]], [[1xtn]], [[6edx]] – mChk Sgk3 PX domain <br /> |
| - | + | ||
| - | + | ||
**[[4f0g]] – smChk Roco4 kinase domain – slime mold<br /> | **[[4f0g]] – smChk Roco4 kinase domain – slime mold<br /> | ||
**[[4yom]] – mChk Sad <br /> | **[[4yom]] – mChk Sad <br /> | ||
**[[4ynz]] – mChk Sad N terminal domain <br /> | **[[4ynz]] – mChk Sad N terminal domain <br /> | ||
**[[5iri]] – mChk Sad residues 592-719<br /> | **[[5iri]] – mChk Sad residues 592-719<br /> | ||
| - | **[[5fvm]] – Chk Tor2 + LST8 – ''Kluyveromyces maximanus''<br /> | ||
**[[5oat]] – Chk – red flour beetle <br /> | **[[5oat]] – Chk – red flour beetle <br /> | ||
| Line 520: | Line 532: | ||
**[[5jk7]] – hChk Vprbp WD repeat domain + VPX + DDB1 + UDG<br /> | **[[5jk7]] – hChk Vprbp WD repeat domain + VPX + DDB1 + UDG<br /> | ||
**[[3wa0]], [[4p7i]] – hChk Vprbp residues 1417-1506 + merlin<br /> | **[[3wa0]], [[4p7i]] – hChk Vprbp residues 1417-1506 + merlin<br /> | ||
| + | **[[5fvm]] - Tor2 + LST8 - ''Kluyveromyces marxianus''<br /> | ||
| + | **[[5kc2]] - yVps15 + Vps34 - Cryo EM<br /> | ||
| + | **[[5dfz]] - yVps15 + Vps34 + Vps30 + VPSAP28 + VPSAP30 - Cryo EM<br /> | ||
**[[4wzx]] – hChk Ulk3 MIT 2 domain + inhibitor<br /> | **[[4wzx]] – hChk Ulk3 MIT 2 domain + inhibitor<br /> | ||
**[[5ci7]] – hChk Ulk1 (mutant) + inhibitor<br /> | **[[5ci7]] – hChk Ulk1 (mutant) + inhibitor<br /> | ||
| Line 528: | Line 543: | ||
**[[2jd5]] – yChk + NPL-3P<br /> | **[[2jd5]] – yChk + NPL-3P<br /> | ||
**[[4lqs]], [[4lqq]], [[4lqp]] – yChk Cbk1 residues 251-756 + Cbk1 activator Mob2<br /> | **[[4lqs]], [[4lqq]], [[4lqp]] – yChk Cbk1 residues 251-756 + Cbk1 activator Mob2<br /> | ||
| - | **[[5kc2]] – yChk Vps15 + Vps34<br /> | ||
**[[3p86]], [[3ppz]] - AtChk Ctr1 + staurosporine<br /> | **[[3p86]], [[3ppz]] - AtChk Ctr1 + staurosporine<br /> | ||
| - | **[[3tpt]] – EcChk Hipa (mutant) + ADP<br /> | ||
| - | **[[3tpv]] – EcChk Hipa + ADP<br /> | ||
| - | **[[4yg7]], [[5k98]] – EcChk Hipa + antitoxin Hipb + DNA<br /> | ||
**[[4f0f]] – smChk Roco4 kinase domain + APPCP <br /> | **[[4f0f]] – smChk Roco4 kinase domain + APPCP <br /> | ||
**[[4f1m]], [[4f1o]] – smChk Roco4 kinase domain (mutant) + APPCP <br /> | **[[4f1m]], [[4f1o]] – smChk Roco4 kinase domain (mutant) + APPCP <br /> | ||
Revision as of 21:37, 18 September 2018
| |||||||||||
3D structures of serine/threonine protein kinase
Updated on 18-September-2018
References
- ↑ Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003 May;3(5):421-9. PMID:12781359
- ↑ Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res. 2004 Nov 15;301(1):60-7. PMID:15501446 doi:http://dx.doi.org/10.1016/j.yexcr.2004.08.016
- ↑ Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Polo-like kinases (Plks) and cancer. Oncogene. 2005 Jan 10;24(2):287-91. PMID:15640844 doi:http://dx.doi.org/10.1038/sj.onc.1208272
- ↑ Dummler B, Ohshiro K, Kumar R, Field J. Pak protein kinases and their role in cancer. Cancer Metastasis Rev. 2009 Jun;28(1-2):51-63. doi: 10.1007/s10555-008-9168-1. PMID:19165420 doi:http://dx.doi.org/10.1007/s10555-008-9168-1
- ↑ Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci. 2007 Aug;64(15):1930-44. PMID:17530463 doi:http://dx.doi.org/10.1007/s00018-007-7045-7
- ↑ Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR, Weber BL. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002 Dec 1;62(23):6997-7000. PMID:12460918
- ↑ Antony R, Emery CM, Sawyer AM, Garraway LA. C-RAF mutations confer resistance to RAF inhibitors. Cancer Res. 2013 Aug 1;73(15):4840-51. doi: 10.1158/0008-5472.CAN-12-4089. Epub, 2013 Jun 4. PMID:23737487 doi:http://dx.doi.org/10.1158/0008-5472.CAN-12-4089
- ↑ Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017. PMID:22500797 doi:http://dx.doi.org/10.1016/j.cell.2012.03.017
- ↑ Ravindran R, Loebbermann J, Nakaya HI, Khan N, Ma H, Gama L, Machiah DK, Lawson B, Hakimpour P, Wang YC, Li S, Sharma P, Kaufman RJ, Martinez J, Pulendran B. The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature. 2016 Mar 24;531(7595):523-7. doi: 10.1038/nature17186. Epub 2016 Mar 16. PMID:26982722 doi:http://dx.doi.org/10.1038/nature17186
- ↑ Atilla-Gokcumen GE, Di Costanzo L, Meggers E. Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3beta. J Biol Inorg Chem. 2010 Sep 7. PMID:20821241 doi:10.1007/s00775-010-0699-x

